Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program

This cross-sectional study estimates the trial capacity of sites participating in the COVID-19 convalescent plasma expanded access program.

Detalles Bibliográficos
Autores principales: Gustafson, M. Sage, Patel, Aman, Hong, Chuan, Meline, Miles, Peña, Daniella, Tang, Charis, Fernandez Lynch, Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582895/
https://www.ncbi.nlm.nih.gov/pubmed/36260335
http://dx.doi.org/10.1001/jamanetworkopen.2022.37540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582895/
https://www.ncbi.nlm.nih.gov/pubmed/36260335
http://dx.doi.org/10.1001/jamanetworkopen.2022.37540

Ejemplares similares